References
Clark DB, Bukstein O, Cornelius J. Alcohol use disorders in adolescents: epidemiology, diagnosis, psychosocial interventions, and pharmacological treatment. Pediatr Drugs 2002: 4(8): 493–502
Survey Research Center, Institute for Social Research, University of Michigan. Monitoring the future [on line]. Available from URL: http://www.monitoringthefuture.org [Accessed 2003 Jan 28]
Cohen P, Cohen J, Kasen S, et al. An epidemiological study of disorders in late childhood and adolescence (I): age- and gender-specific prevalence. J Child Psychol Psychiatry 1993; 34: 851–67
Rohde P, Lewinsohn PM, Seeley JR. Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry 1996; 35: 101–9
American Psychiatric Association. The diagnostic and statistical manual (DSM IV) 4th ed. Washington DC: American Psychiatric Association, 1994
Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children — present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36(7): 980–8
Spitzer R, Williams J, Gibbon B, et al. Structured clinical interview for DSM-III-R. Biometrics Research Development. New York: New York State Psychiatric Institute, 1990
Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. Am J Addict 2001; 10(2): 178–89
Brewer C, Meyers RJ, Johnsen J. Does disulfiram help to prevent relapse in alcohol abuse? CNS Drugs 2002 Nov; 14(5): 329–41
British National Formulary no. 44 [online]. Available from URL: http://www.bnf.org [Accessed 2003 Feb 24]
2003 Mosby’s Drug Consult [online]. Available from URL: http://www.mosbysdrugconsult.com [Accessed 2003 Feb 24]
Garbutt JC, West SL, Carey TS, et al. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281(14): 1318–25
Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 2001; 25(9): 1335–41
Wilde MI, Goa KL. Management of alcohol dependence after detoxification: the potential role of acamprosate. Dis Manage Health Outcomes 1998; 3(1): 35–46
Naltrexone And Alcoholism Treatment Treatment Improvement Protocol (TIP) [online]. Available from URL: http://www.health.org/govpubs/BKD268/28b.aspx [Accessed 2003 Feb 12]
Cornelius JR, Salloum IM, Ehler JG, et al. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54: 700–5
Cornelius JR, Bukstein O, Lynch K, et al. Fluoxetine in adolescents with major depression and an adolescent alcohol use disorder: an open-label trial. Addict Behav 2001; 26: 735–9
Deas D, Randall CL, Roberts JS, et al. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol 2000; 15(6): 461–9
Biederman J, Wilens T, Mick E, et al. Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104: E20
Rights and permissions
About this article
Cite this article
The treatment of alcohol use disorders in adolescents requires greater research. Drugs Ther. Perspect 19, 6–9 (2003). https://doi.org/10.2165/00042310-200319070-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200319070-00003